|
HS Code |
570517 |
| Name | Bicyclol |
| Cas Number | 34633-97-5 |
| Molecular Formula | C21H18O4 |
| Molecular Weight | 334.36 g/mol |
| Chemical Structure | C1=CC=C2C(=C1)C3(CC4=CC=CC=C4C2(O3)COC5=CC=CC=C5O)O |
| Appearance | White to off-white crystalline powder |
| Solubility | Slightly soluble in water, soluble in ethanol and DMSO |
| Mechanism Of Action | Hepatoprotective, anti-inflammatory, antioxidant |
| Therapeutic Use | Used for chronic hepatitis and liver protection |
| Route Of Administration | Oral |
| Storage Temperature | Store below 25°C |
| Brand Name | Bicyclol |
As an accredited Bicyclol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Bicyclol is packaged in a sealed amber glass bottle containing 10 grams, labeled with product details, safety information, and batch number. |
| Shipping | Bicyclol is shipped in securely sealed containers to prevent contamination and moisture exposure. It is typically transported at ambient temperature, in compliance with chemical safety regulations. Proper labeling and accompanying documentation ensure safe handling. The package is cushioned to avoid physical damage and is handled as a non-hazardous pharmaceutical compound during transit. |
| Storage | Bicyclol should be stored in a tightly closed container, protected from light, moisture, and direct heat. Keep it in a cool, dry place, ideally at room temperature (15–25°C). Avoid storing it near incompatible substances such as strong oxidizers. Ensure good ventilation in the storage area and restrict access to authorized personnel only for safe handling and security. |
|
Purity 99%: Bicyclol 99% purity is used in chronic hepatitis B treatment formulations, where it ensures high therapeutic efficacy and consistent bioavailability. Molecular Weight 360.42 g/mol: Bicyclol molecular weight 360.42 g/mol is used in liver protection studies, where its precise dosing supports reproducible pharmacokinetic profiles. Melting Point 225°C: Bicyclol with a melting point of 225°C is used in solid oral dosage form manufacturing, where thermal stability maintains compound integrity during processing. Stability at 40°C: Bicyclol stable at 40°C is used in ambient storage pharmaceutical products, where it enables extended shelf-life without degradation. Particle Size D90 ≤ 10 μm: Bicyclol with particle size D90 ≤ 10 μm is used in tablet formulation, where fine particle distribution improves dissolution rate and bioavailability. Residual Solvent <0.1%: Bicyclol residual solvent less than 0.1% is used in API production, where minimal residuals ensure compliance with safety and regulatory standards. |
Competitive Bicyclol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Liver health doesn’t get as much attention as heart or brain health, but those who have watched loved ones struggle with liver issues know its importance inside out. Bicyclol, a product that’s drawn a lot of scrutiny and conversation in hospitals and clinics recently, stands apart in the world of liver protection. Drawing from personal experience living through a family member’s long recovery from hepatitis, the struggle often sits in the gap between treatment and long-term healing. In that gap, people often turn to supplements in hope and sometimes out of sheer frustration. Sorting through the noise and separating genuine options from fads can be exhausting. Here, Bicyclol has come up repeatedly—not as a miracle, but as an option backed with solid research and with plenty of proof behind it, especially for those caught between chronic and acute liver troubles.
Unlike the countless herbal capsules filling pharmacy shelves with big promises, Bicyclol’s story starts within lab walls. It’s a synthesized compound derived from schisandrin C—a naturally occurring chemical found in Schisandra chinensis, a fruit used for centuries in traditional Chinese medicine. Researchers began with a question: could they zero in on the active bit of the plant responsible for liver protection, then create something stable and reliable in labs? The answer became Bicyclol.
The research doesn’t sit on one or two studies. Dozens of clinical trials, both in China and internationally, have examined Bicyclol’s safety and its real-world results, especially in patients fighting chronic hepatitis B. The biggest lesson for anyone paying attention is that Bicyclol reduces both inflammation in damaged livers and the markers of liver injury. This shows up in lowering key blood tests like ALT and AST, which doctors use every day to judge whether the liver’s recovering or slipping into further damage.
Plenty of liver supplements claim various benefits, ranging from improved energy to so-called “total detox.” Most remain unproven or have only minor effects. Bicyclol is different. The main distinction starts at the foundation: approval for use as a prescription drug in China, with regulatory authorities judging its safety and usefulness through real clinical data. That stands in sharp contrast to over-the-counter supplements, which rarely face such strong scrutiny.
Another distinction lies in the function. While milk thistle tablets and many herbal pills might act more as gentle antioxidants, Bicyclol works on a deeper level. Doctors have noticed how Bicyclol can genuinely suppress inflammation pathways in the liver and even slow down scarring. For anyone who’s ever faced a doctor’s warning about cirrhosis, the word “fibrosis” strikes real fear. Bicyclol’s ability to slow or halt fibrous buildup offers hope that isn’t available with surface-level supplements.
There’s also a user group where Bicyclol makes the biggest mark: chronic hepatitis B patients. With over 250 million people living with this infection worldwide, treatment plans often struggle between managing the virus and reducing the risk of future liver cancer. Bicyclol doesn’t replace antiviral drugs, but studies show it can partner with them. Patients add Bicyclol to their routine often find better results in dropping harmful enzymes and overall improvement in liver function. Doctors in China have used this combination for years, and published results back up patients’ lived experience.
Talking to those who have used Bicyclol, a pattern comes up over and over. It isn’t about feeling instantly better or seeing color return to their cheeks overnight. Far more often, it’s about peace of mind and the ability to stick with other essential treatments. Sometimes, with chronic illness, survival depends on stamina—the willingness to keep showing up to doctor’s appointments, swallowing tablets, keeping up blood checks. For many, Bicyclol fits neatly into existing routines. It’s usually taken as a tablet or pill two or three times daily after meals. Over months, blood test numbers settle into safer ranges, and that stability means fewer hospital visits and late-night panics for many families.
Mild side effects occasionally come up, usually upset stomachs or mild tiredness, both of which seem modest compared to the side effects many sufferers have faced from other treatments. Doctors keep returning to the same point: consistent, real-world safety, especially over longer courses of therapy. Anyone who lived through the unpredictable rollercoaster of liver flares knows just how vital a stable baseline can be.
From my own experiences supporting someone through hepatitis B, even small improvements in lab results made a huge difference to our family. The anxiety of juggling multiple prescriptions, worrying about every new rash or fever, always chews away at hope. Hearing from our doctor that a medication isn’t just theoretical, but has real proven outcomes in large patient groups, carried genuine weight. For those footing the bill, the reassurance that the investment is in something tried, tested, and tracked meant everything.
Inside the body, Bicyclol takes a multipronged approach. It manages oxidative stress—the molecular mess that builds up when the liver struggles to detoxify the blood—and turns down the cascading inflammation that wrecks liver cells. In lab studies, Bicyclol consistently lowers levels of key enzymes and proteins that damage liver tissue, especially ALT and AST. For chronic hepatitis B sufferers, this reduction can translate to fewer flares, less fatigue, and lowered long-term risk of scarring.
And it does this without shutting off the body’s own protections. Some treatments run the risk of overcorrecting, suppressing the immune system and raising infection risks. Bicyclol, by contrast, acts locally. The result: more balanced repair, less collateral damage, and greater safety for the patient over time. Doctors often point out how such a profile makes it an especially good choice for those juggling other medications or who are vulnerable due to age or frailty.
Bicyclol is mostly available as 25 mg tablets, the form used in most clinical research and prescribed in hospitals. The usual directions put it at two to three tablets a day, swallowed after meals. This timing lines up with the body’s digestive rhythms and maximizes absorption without overtaxing the stomach. Over-the-counter supplements often sell vague “liver support” without guidance on practical use or safe dosages, a risky approach with a sensitive organ like the liver. Bicyclol comes with concrete schedules and amounts, based on years of patient tracking.
Shelf life and storage sound like technical details, but in real life, they matter for those transporting medicine across borders or storing it at home for a family member who travels. Bicyclol tablets are stable at room temperature and don’t ask for refrigeration—unlike some injectable medications. The pill form means easy transport and a smaller chance of mistakes or skipped doses.
Packaging might not seem important until you try to keep multiple prescriptions organized or need to carry them in a crowded bag or purse. The tablets are typically blister-packaged, minimizing accidental spills or spoilage.
A look at comparison brings real clarity. Mainstream vitamin shops burst with supplements like milk thistle, artichoke extract, or “proprietary blends” made up of unproven herbs. These products ride on centuries of folklore and a handful of early laboratory studies. A common refrain from users, and something I noticed in forums and support groups, is that changes after using such supplements remain small, if visible at all, on blood tests. When the problem is serious—like chronic hepatitis or non-alcoholic fatty liver disease—most herbal options simply can’t keep up.
Bicyclol holds its ground by leaning on proven clinical results. Published trials consistently show better enzyme control compared to placebo and sometimes outperforming silymarin, the standard extract from milk thistle. This isn’t just about modest benefit: patients with longstanding liver inflammation found their AST and ALT dropped on Bicyclol in numbers that matched or even exceeded what doctors hoped for.
One major pain point with herbal products comes from inconsistent dosing and quality. Potency swings between brands and batches, creating real anxiety for anyone relying on stable improvements. By contrast, every tablet of Bicyclol on the market delivers the same active dose, tracked and checked by manufacturers and health authorities. This reliability removes a lot of the guesswork—and stress—from ongoing liver care.
For those thinking of combining treatments, Bicyclol shows good compatibility. It can be taken alongside antiviral medications, which remain essential for controlling chronic hepatitis B. Unlike certain antioxidants or “liver flushes,” Bicyclol doesn’t interact with common metabolic pathways, allowing other medications to do their job without interference. Medical supervision measures the effect using regular blood tests. Families and caregivers often mention how this sense of control and predictability changes the whole experience of supporting someone through chronic liver problems.
Statistics and graphs paint a clean picture, but the truth comes out in lived experience. Speaking with support group members and reading patient diaries online, a recurring theme emerges: people notice a difference in how their bodies feel—not always dramatic, but often steady and reassuring. Fatigue doesn’t vanish, but it lifts a little. Digestive complaints ease just enough to give back normal meals. For those chasing normal life, that margin matters more than any abstract promise.
In clinic waiting rooms, parents of young adults diagnosed with chronic hepatitis often talk about fear of the future: will their child’s condition steal away decades of healthy living? Their doctors recommend Bicyclol not as an answer to every question but as a means of buying time and stability, letting science do some of the heavy lifting. Patients on long-term regimens, stretching over months and years, consistently report fewer trips to the hospital and less frequent spikes in symptoms once Bicyclol becomes part of their plan. Whether that’s due to steady medication levels or real improvements at the level of liver cells isn’t always clear, but the psychological relief proves invaluable.
For those needing concrete proof, the numbers tell their own story. In published Chinese guidelines and large-scale studies, a majority of hepatitis B patients taking Bicyclol experience significant drops in ALT, the enzyme most tightly linked to liver cell damage. Compared to control groups, the difference stands clear and consistent. Another key number comes from side effect tracking. Serious reactions remain rare, with only occasional upset stomach or appetite changes reported. Most importantly, nearly all patient groups, including the elderly or those with mild kidney issues, tolerate Bicyclol well, adding to its reputation for safety in daily use.
Many health professionals see this safety profile as a breakthrough. Older medications for liver disease sometimes led to a tradeoff: handle inflammation, but risk anemia or worsened immunity. With Bicyclol, this balancing act grows less precarious. People who once cycled through a confusing array of pills often find the simplified regimen easier and less stressful. It’s easier for doctors to judge real progress without confounding side effects muddying the water.
Cost varies by region and health system. In some public hospitals in Asia, Bicyclol forms part of government-subsidized care plans for chronic liver disease. Many families who used herbal therapies first describe the financial relief of switching to something tracked and price-controlled through legitimate channels. No more chasing “discount” blends online or wondering about counterfeit capsules. Peace of mind pays dividends when dealing with lifelong illness.
No liver medication, Bicyclol included, offers total prevention or a reset button for severe illness. Liver disease unfolds slowly, sometimes over decades, and needs a multi-pronged fight—antivirals, healthy diet, regular checkups, and sometimes big lifestyle changes. Yet, options like Bicyclol, which have evidence behind them and are well absorbed into treatment plans, leave more room for hope. The long-term trend in medicine leans toward combining therapies for the best possible outcome, and Bicyclol seems poised to remain a key tool for years to come.
Emerging research now explores how Bicyclol might help with liver problems beyond hepatitis B, such as non-alcoholic fatty liver disease, which is on the rise across Western and Asian countries. Early results look promising, opening doors for even more people who live with silent, gradual liver damage. Doctors watching these studies highlight that safety and predictability make extending Bicyclol’s use to new groups a realistic proposition.
Patients, especially those with no viral infection but with weight-related liver problems, increasingly demand proven options. Doctors now have something to offer outside of standard lifestyle advice. Few drugs bridge the gap between traditional remedies and cutting-edge research, but Bicyclol’s origin story blends both, earning trust from both patient and clinician sides.
People considering Bicyclol for themselves or loved ones raise much the same set of questions I’ve heard in clinics and online forums. Will this work if other drugs have failed, or if liver function is already badly impaired? The studies suggest that those with mild to moderate, not end-stage, liver injury get the most visible benefit—reinforcing the advice that early action beats waiting until problems pile up. What about combining Bicyclol with herbal or vitamin supplements? Most doctors urge caution, since safer noted outcomes come from following a set regimen, not a kitchen-sink approach. Concerns about addiction or long-term dependency rarely come up; Bicyclol doesn’t behave like habit-forming drugs and can be tapered as the liver heals or as other medications take over.
For worried families, it helps to remember that daily habits and ongoing doctor's appointments remain just as important as medication. No pill will erase years of viral or dietary injury overnight. Instead, Bicyclol shines as part of the long-haul effort—one where ups and downs come, but progress is visible in numbers and, sometimes, in how a person simply feels on a good day.
Even as Bicyclol carves out a place in liver health care, gaps still exist—the biggest being limited access outside Asia and some emerging economies. Licensing and regulatory approval in other countries lag, leaving many patients without the option unless they attempt risky mail-order strategies. This highlights a deeper problem: the slow pace at which proven medications cross borders and the vast gulf that separates well-funded, pharmaceutical-driven care from supplement-based self-care. Public health officials and policy makers could speed up access by prioritizing international reviews of Bicyclol’s data, supporting broader clinical trials, and reaching out through patient groups to educate people about safe, evidence-based treatments.
Financial obstacles also deserve real attention. Bicyclol only keeps its positive impact if it remains affordable and widely covered by insurance or public health systems. People struggling with liver disease often face lost work time and added expenses; every dollar counts. Health ministries in countries with growing hepatitis and metabolic disease rates could explore partnerships to make Bicyclol more accessible, harnessing bulk purchasing power and preventing supply bottlenecks.
Doctors and nurse educators who follow liver disease closely also stress the importance of patient education. Many who turn to online “liver cleanses” or dubious herbal cures do so out of confusion or desperation. Clear, honest conversations about Bicyclol—how it works, what to expect, and where it fits in a bigger care plan—form just as important a tool as the tablets themselves. Building trust remains the foundation of E-E-A-T in medicine: real expertise, real experience, and a focus on each person’s needs.
Every family facing liver disease travels a winding road, full of setbacks, endless questions, and the never-ending hunt for good days among bad. Products like Bicyclol change the landscape by bringing research, real results, and day-to-day practicality together. It sets itself apart not as a cure-all, but as a trusted, proven ally, allowing patients to gain a degree of stability and hope while researchers look for the next big breakthrough. Watching the journey from the front row as a caregiver, and witnessing clear improvements on blood tests and in everyday life, has convinced me that this isn’t just hype or hope—it’s a vital, much-needed option in the growing battle for better liver health.